Skip to main content

Our Insulin management solutions

About us

About us

At MiniMed, our story starts with you MiniMed is the flagship diabetes brand of Medtronic; The leading Global healthcare technology solutions provider.

MiniMed is dedicated to empowering people to manage their diabetes with innovative, easy to use technology and support.

Built on over 40 years of Innovation, MiniMed helps you spend less time managing diabetes and more time living brilliantly.

References

  1. Medtronic data on file. Pivotal Trial (Age 14-75). N=157. 2020; 16 US sites
  2. Based on the recommended MiniMed™Mio™ Advance and MiniMed™Quick-set™ insulin infusion set change every 2-3 days compared to 4 injections a day for 30 days
  • 1.Carlson AL, et al. Diab Tech and Therap. 2021; DOI 10.1089/dia.2021.0319
  • 2.Collyns OJ, et al. Diabetes Care. 2021;44(4):969-975.
  • 3.Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMed ™ 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
  • * MDI = Multiple Daily Injections
  • ** Time in Range is the percentage of time that people with type 1 diabetes spend in the optimal glycemic range of 70-180 mg/dL (3.9-10 mmol/L).
  • # Multiple Daily Injections (3 bolus and 1 basal insulin per day) requires 28 injections per week vs. one infusion set change every two to three days.